[Attitude of the clinican toward adverse effects of protease inhibitors].

Author: BreuxJ P, ChampagneX, NicolB, PasdeloupT, PéraultM C, RemblierC, VandelB

Paper Details 
Original Abstract of the Article :
Since 1996, marketing of new drugs called protease inhibitors has revolutionized the treatment of patients suffering from AIDS. The side-effects of this new therapeutic family are quite well known but we wanted to evaluate the attitude of the clinician: can these adverse effects be corrected by symp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/11201980

データ提供:米国国立医学図書館(NLM)

The Impact of Protease Inhibitors on AIDS Treatment

The advent of [protease inhibitors (PIs)] in 1996 marked a significant turning point in the treatment of [AIDS]. This study delves into the [attitude of clinicians] towards the [adverse effects] of these new medications. The researchers conducted a [retrospective survey] of patients treated with PIs, examining the [types of side effects] encountered and the management strategies employed by clinicians. It's like exploring the impact of a new resource in a desert, understanding the challenges and opportunities it presents for a struggling community.

Navigating the Side Effects of Protease Inhibitors

The study found that [PIs can cause a range of side effects] including [gastrointestinal, neurological, renal, and metabolic effects]. Clinicians reported that [some side effects were manageable with symptomatic treatment] while [others required discontinuation of the PI]. This research highlights the importance of careful monitoring and individualized management strategies to minimize the impact of these side effects.

The Need for Personalized Treatment Plans

This study underscores the need for [personalized treatment plans] when using PIs for AIDS. Considering the [individual patient's risk factors and tolerance to side effects] is crucial for maximizing treatment effectiveness and minimizing adverse outcomes. This approach, like a skilled desert guide adjusting to changing conditions, ensures a safe and effective journey for patients through the complexities of AIDS management.

Dr. Camel's Conclusion

The discovery of protease inhibitors was a major breakthrough in the fight against AIDS, like finding a new oasis in the desert. This study, like a caravan traversing a desert landscape, highlights the importance of understanding the complexities of these medications and managing their potential side effects. By carefully monitoring patients and adapting treatment plans to individual needs, we can navigate the challenges of AIDS treatment and ensure a better future for those affected by this devastating disease.

Date :
  1. Date Completed 2001-03-08
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

11201980

DOI: Digital Object Identifier

11201980

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.